Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • Sperm damage: Decoding...

    Sperm damage: Decoding link between repeated miscarriages and men

    Written by Medha Baranwal Baranwal Published On 2019-04-03T20:28:55+05:30  |  Updated On 3 April 2019 8:28 PM IST
    Sperm damage: Decoding link between repeated miscarriages and men

    LONDON: Repeated miscarriages are often attributed to a problem in the affected women who are then made to undergo many tests to determine the root cause. However, a new study has found that recurrent pregnancy loss (RPL) may also occur due to sperm DNA damage in the male partner. The study was presented at the ENDO 2019: The Endocrine Society Annual Meeting.


    Recurrent pregnancy loss is defined as the consecutive loss of three or more pregnancies before 20 weeks gestation. It occurs in 1-2% of couples, and about half of cases are unexplained. Channa Jayasena, M.D., Ph.D., of Imperial College London in London, U.K., and colleagues conducted the study to assess whether male partners of women with RPL may have an increased risk of sperm DNA damage, which is known to impair fertility.


    "Affected women undergo many tests to determine the cause, but many cases have no identified cause," said Dr. Jayasena. Male partners of women with RPL do not routinely undergo an assessment to see if they play a role. She further adds that, however, we know that sperm play an important role in the formation of the placenta, which is critical for the survival of an unborn baby.


    Also Read: Progestogen Therapy prevents recurrent miscarriage

    For the study, the researchers compared 50 healthy men whose partners had not experienced miscarriages with 63 men whose partners were affected by RPL. They measured levels of sex hormones such as testosterone, the number, and behavior of sperm using a microscope, and further molecular tests. They also measured the level of damage to sperm DNA, and level of a chemical entity called reactive oxygen species, which can damage cells such as sperm in the semen of men.


    The RPL partners (females) were a little older (average age 37 vs 30 years) and had a slightly higher body mass index (27.6 vs 24.8 kg/m2) compared with controls. Rates of smoking and alcohol consumption were similar in both groups.


    Key findings of the study include:

    • About 3.4% of sperm had normal morphology among the males of couples whose partners suffered recurrent miscarriages, compared with 4.5% of controls' sperm, and DNA damage was more than doubled in RPL male partners (mean DNA fragmentation index [DFI], 16.3) compared with controls (DFI, 7.4).

    • The greatest difference between the groups was in seminal reactive oxygen species levels, which were fourfold higher in RPL male partners compared with controls (9.3 vs 2.3 RLU/sec/106 sperm).

    • The RPL male partners also had slightly lower but nonsignificant mean serum morning testosterone than controls (15.8 vs 17.9 nmol/L).


    Also Read: Pregnancy loss and multiple births increase heart disease risk

    "Our study suggests that it may be useful to investigate if male partners of women with RPL have abnormalities in their reproductive function," Jayasena said. "It also opens up a new potential 'drug target'; it may be possible to design future drugs to stop sperm DNA damage to treat couples with RPL and reduce the risk of miscarriage."

    Channa JayasenaDNA damageDNA fragmentation indexENDO 2019Miscarriageplacenta formationpregnancy lossreactive oxygen speciesrecurrent pregnancy lossrepeated miscarriagessemenseminalspermsperm damagesperm DNAtestosterone

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok